Showing results (1471-1480 of 1,523) with videos related to

Sort By:
Pageof 153
The Lancet. Oncology|November 28, 2017
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 studyWen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.
Journal of Cancer Research and Clinical Oncology|June 14, 2023
Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS studyQing Zhou, He-Long Zhang, Li-Yan Jiang, et al.
Targeted Oncology|January 12, 2022
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in ChinaHai-Yan Tu, Jifeng Feng, Meiqi Shi, et al.
The Lancet. Oncology|June 21, 2013
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trialYi-Long Wu, Jin Soo Lee, Sumitra Thongprasert, et al.
JAMA Network Open|June 2, 2023
Effectiveness of a Quality Improvement Intervention on Reperfusion Treatment for Patients With Acute Ischemic Stroke: A Stepped-Wedge Cluster Randomized Clinical TrialChun-Juan Wang, Hong-Qiu Gu, Li-Xia Zong, et al.
JTO Clinical and Research Reports|January 3, 2022
Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN StudyXue-Ning Yang, Hong-Hong Yan, Jun Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 7, 2018
The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)Song-Tao Xu, Jun-Jie Xi, Wen-Zhao Zhong, et al.
JAMA|February 9, 2023
Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical TrialHui-Sheng Chen, Yu Cui, Zhong-He Zhou, et al.
JAMA Oncology|June 13, 2024
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled TrialSong Dong, Zhen Wang, Jia-Tao Zhang, et al.
Eclinicalmedicine|October 2, 2023
Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trialSi-Yang Maggie Liu, Xiao-Rong Dong, Zhen Wang, et al.
Pageof 153